Prevention of in vitro lipolysis by tetrahydrolipstatin

Clinical Chemistry

Volumn 46, Issue 7, 2000, Pages 950-954

  Krebs, Michael ^a   Stingl, Harald ^a   Nowotny, Peter ^a   Weghuber, Daniel ^a   Bischof, Martin ^a   Waldhäusl, Werner ^a   Roden, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLYCEROL; HEPARIN; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPOLYSIS; MALE; NORMAL HUMAN; TEMPERATURE SENSITIVITY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033939992     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.7.950     Document Type: Article

References (24)

1. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YDI. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-4.
2. Gordon ES. Non-esterified fatty acids in blood of obese and lean subjects. Am J Clin Nutr 1960;8:740-7.
3. Bagdade JD, Porte D, Bierman EL. The interaction of diabetes and obesity on the regulation of fat mobilization in man. Diabetes 1969;18:759-72.
4. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KGMM. Metabolic effects of suppression of nonesterified fatty acid levels with Acipimox in obese NIDDM subjects. Diabetes 1992;41: 1400-8.
5. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999;48:1836-41.
6. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Investig 1994;93: 2438-46.
7. Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 1991;40:686-92.
8. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA. Time dependance of the interaction between lipid and glucose in humans. Am J Physiol 1989;257:E49-56.
9. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Investig 1999;103:253-9.
10. Felber JP, Vanotti A. Effects of fat infusion on glucose tolerance and insulin plasma levels. Med Exp 1964;10:153-6.
11. Grossman MI, Moeller HC, Palm L. Effect of lipemia and heparin on free fatty acid concentration of serum in humans. Proc Soc Exp Biol Med 1955;90:106-9.
12. Lee KU, Lee HK, Koh CS, Min HK. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 1988;31:285-90.
13. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fūrnsinn C, et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 1999;48:358-64.
14. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Investig 1996;97:2859-65.
15. Yki-Järvinen H, Puhakainen I, Koivisto VA. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 1991;72:1268-77.
16. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of free fatty acids. J Lipid Res 1993;34:1021-8.
17. Lookene A, Skottova N, Olivecrona G. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat). Eur J Biochem 1994;222:395-403.
18. Zambon A, Schmidt I, Beisiegel U, Brunzell JD. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. J Lipid Res 1996;37:2394-404.
19. Hultin M, Bengtsson-Olivecrona G, Olivecrona T. Release of lipoprotein lipase to plasma by triacylglycerol emulsions. Biochim Biophys Acta 1992;1125:97-103.
20. Brunzell JD, Porte D, Bierman EL. Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus. Metabolism 1975;24:1123-37.
21. Curry S, Mandelkow H, Brick P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998;5: 827-35.
22. Lobo LB, Wilton DC. Inhibition of lipoprotein lipase activity by tetrahydrolipstatin. Biochem Soc Trans 1997;25:S682.
23. Ko J, Small DM. Behavior of tetrahydrolipstatin in biological model membranes and emulsions. J Lipid Res 1997;38:1544-52.
24. Korn ED, Quigley TW Jr. Lipoprotein lipase of chicken adipose tissue. J Biol Chem 1957;226:833-9.